• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

内皮细胞衍生组织因子途径抑制剂调节动脉血栓形成,但对于发育或止血并非必需。

Endothelial-derived tissue factor pathway inhibitor regulates arterial thrombosis but is not required for development or hemostasis.

机构信息

Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA.

出版信息

Blood. 2010 Sep 9;116(10):1787-94. doi: 10.1182/blood-2009-10-250910. Epub 2010 Jun 1.

DOI:10.1182/blood-2009-10-250910
PMID:20516367
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2947398/
Abstract

The antithrombotic surface of endothelium is regulated in a coordinated manner. Tissue factor pathway inhibitor (TFPI) localized at the endothelial cell surface regulates the production of FXa by inhibiting the TF/VIIa complex. Systemic homozygotic deletion of the first Kunitz (K1) domain of TFPI results in intrauterine lethality in mice. Here we define the cellular sources of TFPI and their role in development, hemostasis, and thrombosis using TFPI conditional knockout mice. We used a Cre-lox strategy and generated mice with a floxed exon 4 (TFPI(Flox)) which encodes for the TFPI-K1 domain. Mice bred into Tie2-Cre and LysM-Cre lines to delete TFPI-K1 in endothelial (TFPI(Tie2)) and myelomonocytic (TFPI(LysM)) cells resulted in viable and fertile offspring. Plasma TFPI activity was reduced in the TFPI(Tie2) (71% ± 0.9%, P < .001) and TFPI(LysM) (19% ± 0.6%, P < .001) compared with TFPI(Flox) littermate controls. Tail and cuticle bleeding were unaffected. However, TFPI(Tie2) mice but not TFPI(LysM) mice had increased ferric chloride-induced arterial thrombosis. Taken together, the data reveal distinct roles for endothelial- and myelomonocytic-derived TFPI.

摘要

内皮细胞的抗血栓表面是协调调节的。组织因子途径抑制剂(TFPI)定位于内皮细胞表面,通过抑制 TF/VIIa 复合物来调节 FXa 的产生。TFPI 的第一个 Kunitz(K1)结构域的全身性纯合缺失导致小鼠宫内致死。在这里,我们使用 TFPI 条件性敲除小鼠来定义 TFPI 的细胞来源及其在发育、止血和血栓形成中的作用。我们使用 Cre-lox 策略生成了一个 TFPI(Flox)的 floxed 外显子 4(编码 TFPI-K1 结构域)的小鼠。将这些小鼠繁殖到 Tie2-Cre 和 LysM-Cre 系中,以敲除内皮细胞(TFPI(Tie2))和髓系细胞(TFPI(LysM))中的 TFPI-K1,得到了存活且可育的后代。与 TFPI(Flox)同窝仔相比,TFPI(Tie2)(71%±0.9%,P<.001)和 TFPI(LysM)(19%±0.6%,P<.001)的血浆 TFPI 活性降低。尾巴和表皮出血不受影响。然而,只有 TFPI(Tie2)小鼠而不是 TFPI(LysM)小鼠的氯化铁诱导的动脉血栓形成增加。总之,这些数据揭示了内皮细胞和髓系细胞衍生的 TFPI 的不同作用。

相似文献

1
Endothelial-derived tissue factor pathway inhibitor regulates arterial thrombosis but is not required for development or hemostasis.内皮细胞衍生组织因子途径抑制剂调节动脉血栓形成,但对于发育或止血并非必需。
Blood. 2010 Sep 9;116(10):1787-94. doi: 10.1182/blood-2009-10-250910. Epub 2010 Jun 1.
2
Endogenous tissue factor pathway inhibitor in vascular smooth muscle cells inhibits arterial thrombosis.血管平滑肌细胞中的内源性组织因子途径抑制剂抑制动脉血栓形成。
Front Med. 2017 Sep;11(3):403-409. doi: 10.1007/s11684-017-0522-y. Epub 2017 May 27.
3
Deletion of tissue factor pathway inhibitor isoform beta or gamma, but not alpha, improves clotting in hemophilic mice.组织因子途径抑制物异构体β或γ缺失,而非α缺失,可改善血友病小鼠的凝血功能。
J Thromb Haemost. 2024 Oct;22(10):2681-2691. doi: 10.1016/j.jtha.2024.06.006. Epub 2024 Jun 24.
4
The effect of vascular smooth muscle cell-targeted expression of tissue factor pathway inhibitor in a murine model of arterial thrombosis.组织因子途径抑制剂在血管平滑肌细胞靶向表达对小鼠动脉血栓形成模型的影响。
Thromb Haemost. 2004 Sep;92(3):495-502. doi: 10.1160/TH04-01-0006.
5
Tissue factor pathway inhibitor gene disruption produces intrauterine lethality in mice.组织因子途径抑制物基因缺失导致小鼠宫内致死。
Blood. 1997 Aug 1;90(3):944-51.
6
Re-evaluation of mouse tissue factor pathway inhibitor and comparison of mouse and human tissue factor pathway inhibitor physiology.重新评估小鼠组织因子途径抑制剂并比较小鼠和人组织因子途径抑制剂的生理学特性。
J Thromb Haemost. 2018 Nov;16(11):2246-2257. doi: 10.1111/jth.14288. Epub 2018 Oct 22.
7
Murine strain differences in hemostasis and thrombosis and tissue factor pathway inhibitor.鼠种间止血、血栓形成和组织因子途径抑制剂的差异。
Thromb Res. 2010 Jan;125(1):84-9. doi: 10.1016/j.thromres.2009.03.006. Epub 2009 Apr 26.
8
A balance between tissue factor and tissue factor pathway inhibitor is required for embryonic development and hemostasis in adult mice.成年小鼠的胚胎发育和止血需要组织因子与组织因子途径抑制剂之间保持平衡。
Blood. 2005 Apr 1;105(7):2777-82. doi: 10.1182/blood-2004-09-3724. Epub 2004 Dec 14.
9
Activated protein C up-regulates procoagulant tissue factor activity on endothelial cells by shedding the TFPI Kunitz 1 domain.激活蛋白 C 通过裂解 TFPI 上的 Kunitz1 结构域而上调内皮细胞的促凝组织因子活性。
Blood. 2011 Jun 9;117(23):6338-46. doi: 10.1182/blood-2010-10-316257. Epub 2011 Apr 7.
10
Small peptides blocking inhibition of factor Xa and tissue factor-factor VIIa by tissue factor pathway inhibitor (TFPI).小分子肽可阻断组织因子途径抑制物(TFPI)对因子 Xa 和组织因子-因子 VIIa 的抑制作用。
J Biol Chem. 2014 Jan 17;289(3):1732-41. doi: 10.1074/jbc.M113.533836. Epub 2013 Nov 25.

引用本文的文献

1
Vascular Endothelium in Health and Disease: Structure, Function, Assessment and Role in Metabolic Disorders.健康与疾病中的血管内皮:结构、功能、评估及在代谢紊乱中的作用
Vasc Health Risk Manag. 2025 Sep 3;21:729-747. doi: 10.2147/VHRM.S519426. eCollection 2025.
2
The Link Between Venous and Arterial Thrombosis: Is There a Role for Endothelial Dysfunction?静脉血栓与动脉血栓之间的联系:内皮功能障碍是否起作用?
Cells. 2025 Jan 20;14(2):144. doi: 10.3390/cells14020144.
3
Cardiovascular Risk in Philadelphia-Negative Myeloproliferative Neoplasms: Mechanisms and Implications-A Narrative Review.费城阴性骨髓增殖性肿瘤的心血管风险:机制与影响——一篇叙述性综述
Curr Issues Mol Biol. 2024 Aug 2;46(8):8407-8423. doi: 10.3390/cimb46080496.
4
TFPI from erythroblasts drives heme production in central macrophages promoting erythropoiesis in polycythemia.红细胞来源的 TFPI 驱动中巨噬细胞的血红素生成,从而促进红细胞生成增多症中的红细胞生成。
Nat Commun. 2024 May 10;15(1):3976. doi: 10.1038/s41467-024-48328-8.
5
Nanogold-coated stent facilitated non-invasive photothermal ablation of stent thrombosis and restoration of blood flow.纳米金涂层支架有助于对支架血栓形成进行非侵入性光热消融并恢复血流。
Nanoscale Adv. 2024 Jan 30;6(5):1497-1506. doi: 10.1039/d3na00751k. eCollection 2024 Feb 27.
6
Convergence of coronary artery disease genes onto endothelial cell programs.冠状动脉疾病相关基因汇聚到内皮细胞程序中。
Nature. 2024 Feb;626(8000):799-807. doi: 10.1038/s41586-024-07022-x. Epub 2024 Feb 7.
7
Thromboinflammation in Myeloproliferative Neoplasms (MPN)-A Puzzle Still to Be Solved.骨髓增殖性肿瘤(MPN)中的血栓炎症——一个待解决的难题。
Int J Mol Sci. 2022 Mar 16;23(6):3206. doi: 10.3390/ijms23063206.
8
Regulation of coagulation by tissue factor pathway inhibitor: Implications for hemophilia therapy.组织因子途径抑制剂对凝血的调节:对血友病治疗的影响。
J Thromb Haemost. 2022 Jun;20(6):1290-1300. doi: 10.1111/jth.15697. Epub 2022 Mar 27.
9
The contribution of TFPIα to the hemostatic response to injury in mice.TFPIα 对小鼠损伤止血反应的贡献。
J Thromb Haemost. 2021 Sep;19(9):2182-2192. doi: 10.1111/jth.15430. Epub 2021 Jul 14.
10
Intrauterine lethality in Tfpi gene disrupted mice is differentially suppressed during mid- and late-gestation by platelet TFPIα overexpression.Tfpi 基因敲除小鼠的宫内致死性在中晚期妊娠时被血小板 TFPIα 过表达差异抑制。
J Thromb Haemost. 2021 Jun;19(6):1483-1492. doi: 10.1111/jth.15299. Epub 2021 Apr 12.

本文引用的文献

1
A turbidimetric assay for the measurement of clotting times of procoagulant venoms in plasma.一种用于测量血浆中促凝血毒液凝血时间的比浊测定法。
J Pharmacol Toxicol Methods. 2010 Jan-Feb;61(1):27-31. doi: 10.1016/j.vascn.2009.06.004. Epub 2009 Jul 14.
2
Temporal expression of alternatively spliced forms of tissue factor pathway inhibitor in mice.组织因子途径抑制剂可变剪接形式在小鼠中的时序表达
J Thromb Haemost. 2009 Jul;7(7):1106-13. doi: 10.1111/j.1538-7836.2009.03454.x. Epub 2009 Apr 24.
3
Combined tissue factor pathway inhibitor and thrombomodulin deficiency produces an augmented hypercoagulable state with tissue-specific fibrin deposition.组织因子途径抑制剂和血栓调节蛋白联合缺乏会产生增强的高凝状态,并伴有组织特异性纤维蛋白沉积。
J Thromb Haemost. 2008 Jan;6(1):111-7. doi: 10.1111/j.1538-7836.2007.02817.x. Epub 2007 Oct 25.
4
Active tissue factor pathway inhibitor is expressed on the surface of coated platelets.活性组织因子途径抑制物在包被血小板表面表达。
Blood. 2007 Mar 1;109(5):1931-7. doi: 10.1182/blood-2006-07-037283. Epub 2006 Nov 2.
5
Gene targeting methods for studying nuclear transport factors in mice.用于研究小鼠核转运因子的基因靶向方法。
Methods. 2006 Aug;39(4):370-8. doi: 10.1016/j.ymeth.2006.06.009.
6
Fetomaternal cross talk in the placental vascular bed: control of coagulation by trophoblast cells.胎盘血管床中的母婴相互作用:滋养层细胞对凝血的控制。
Blood. 2006 Apr 15;107(8):3173-80. doi: 10.1182/blood-2005-10-4111. Epub 2005 Dec 27.
7
Endothelial cell-specific expression of Cre recombinase in transgenic mice.转基因小鼠中Cre重组酶的内皮细胞特异性表达。
Yi Chuan Xue Bao. 2005 Sep;32(9):909-15.
8
Vascular endothelium is critically involved in the hypotensive and hypovolemic actions of atrial natriuretic peptide.血管内皮在心房利钠肽的降压和低血容量作用中起关键作用。
J Clin Invest. 2005 Jun;115(6):1666-74. doi: 10.1172/JCI23360.
9
A balance between tissue factor and tissue factor pathway inhibitor is required for embryonic development and hemostasis in adult mice.成年小鼠的胚胎发育和止血需要组织因子与组织因子途径抑制剂之间保持平衡。
Blood. 2005 Apr 1;105(7):2777-82. doi: 10.1182/blood-2004-09-3724. Epub 2004 Dec 14.
10
Role for the Kunitz-3 domain of tissue factor pathway inhibitor-alpha in cell surface binding.组织因子途径抑制物-α的Kunitz-3结构域在细胞表面结合中的作用。
Circulation. 2004 Dec 7;110(23):3567-72. doi: 10.1161/01.CIR.0000148778.76917.89. Epub 2004 Nov 22.